FA
LLY icon

Friess Associates’s Eli Lilly LLY Stock Holding History

Friess Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,500
Closed -$1.88M – 131
2019
Q1 		$1.88M Sell
14,500
-14,500
-50% -$1.76M 0.14% 95
2018
Q4 		$3.36M Buy
+29,000
New +$3.24M 0.29% 85
2017
Q3 		– Sell
-39,900
Closed -$3.28M – 114
2017
Q2 		$3.28M Sell
39,900
-153,100
-79% -$12.5M 0.3% 79
2017
Q1 		$16.2M Buy
193,000
+73,000
+61% +$5.85M 1.53% 21
2016
Q4 		$8.83M Buy
+120,000
New +$8.94M 0.87% 57
2016
Q1 		– Sell
-185,000
Closed -$15.6M – 160
2015
Q4 		$15.6M Hold
185,000
– – 1.45% 30
2015
Q3 		$15.5M Buy
+185,000
New +$15.6M 1.44% 29

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Friess Associates's LLY Position: Q2 2019 in Review

Friess Associates sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 14,500 shares — an estimated $1.88M sold.

Friess Associates first reported a position in LLY in Q3 2015 and held it in 7 quarters. The position peaked at $16.2M in Q1 2017. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Friess Associates reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Friess Associates sold 14,500 Eli Lilly shares in Q2 2019, an estimated $1.88M.
  • Friess Associates first reported a position in Eli Lilly in Q3 2015 and held it in 7 quarters.
  • Friess Associates's Eli Lilly position peaked at $16.2M in Q1 2017.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Friess Associates's 13F filing for Q2 2019, filed 14 Aug 2019.